Grants available in 2010
Up to a maximum of £100k in funds is available to fund innovative research into the cause, inheritance, diagnosis, management and treatment of CGD.
Calls for preliminary applications were posted in the journal Nature on the 10th June 2010.
Timetable for Grant Applications in 2010
- Preliminary applications to be received by 30th July 2010
- Applicants informed of decision following preliminary review by 13th September 2010
- Deadline for full applications by 15th November 2010
- Review by the Medical and Scientific Advisory Panel in January 2011
- Applicants informed of Trustee's funding decisions in February 2011
Types of award
Project grants
The purpose of these awards is to provide support for a time-limited project designed to answer a single question or a small group of related questions. Such questions must be directed towards furthering our understanding of CGD and/or developing effective treatments for the condition and that fit within the priority areas. Support is provided for up to three years.
Innovative Basic Grant Awards
These are one-year grant awards to fund work that is fundamental to the understanding of CGD. Their aim is to provide support for a short-term, small-scale pilot or proof of concept research projects. Funds are available up to £40,000.
Ph.D. Studentships
Ph.D studentships are offered to exceptional candidates in laboratories that have a proven track record of research in CGD. The studentships are designed to encourage the best young science graduates to embark on a research career in CGD. Funds are available for up to £75,000 for three years.
IMPORTANT NOTE :
The information contained on this website is intended only as a guideline, not as a substitute for medical advice. Always consult your doctor if you or your child has any CGD symptoms or concerns.
© 2001-2007 The Chronic Granulomatous Disorder (CGD) Research Trust
Registered Charity No. 1003425 email:cgd@cgdrt.co.uk
The CGD Research Trust is a member of the Association of Medical Research Charities (AMRC), the Genetic Interest Group (GiG) and an associate member of the International Patient Organisation of Primary Immunodeficiencies (IPOPI)
Site Map | Terms and Conditions | Privacy
